Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,925 | 31,230 | 42,791 | 51,621 | 45,754 |
| Other current assets | 450 | 450 | 15,200 | 15,000 | 15,000 |
| TOTAL | $24,673 | $32,950 | $60,257 | $68,307 | $62,710 |
| Non-Current Assets | |||||
| PPE Net | 1,008 | 1,060 | 919 | 1,011 | 1,024 |
| Other Non-Current Assets | 11,648 | 12,079 | 1,995 | 2,033 | 3,219 |
| TOTAL | $12,656 | $13,139 | $2,914 | $3,044 | $4,243 |
| Total Assets | $37,329 | $46,089 | $63,171 | $71,351 | $66,953 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,742 | 1,205 | 4,544 | 3,549 | 778 |
| Accrued Expenses | 3,444 | 4,659 | 18,644 | 17,824 | 18,564 |
| TOTAL | $7,511 | $7,277 | $24,059 | $22,423 | $20,815 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,935 | 10,371 | 11,836 | 13,301 | 15,133 |
| Other Non-Current Liabilities | 9,918 | 10,330 | 503 | 695 | 1,648 |
| TOTAL | $18,853 | $20,701 | $12,339 | $13,996 | $16,781 |
| Total Liabilities | $26,364 | $27,978 | $36,398 | $36,419 | $37,596 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 891 | 812 | 809 | 801 | 794 |
| Common Shares | 11 | 11 | 10 | 10 | 7 |
| Retained earnings | -143,408 | -135,772 | -126,669 | -117,722 | -108,554 |
| TOTAL | $10,965 | $18,111 | $26,773 | $34,932 | $29,357 |
| Total Liabilities And Equity | $37,329 | $46,089 | $63,171 | $71,351 | $66,953 |